Skip to main content
logo
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
83.68
+0.64 (0.77%)
At close: Jul 28, 2026, 4:00 PM EDT
84.80
+1.12 (1.34%)
After-hours: Jul 28, 2026, 7:58 PM EDT

Edwards Lifesciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
1,7411,6491,5701,5531,5321,4131,3861,3541,3691,3301,2661,2431,2961,4601,3481,3191,3741,3411,3301,310
Revenue Growth
13.63%16.70%13.26%14.67%11.89%6.23%9.43%8.93%5.70%-8.89%-6.07%-5.73%-5.71%8.83%1.40%0.67%-0.15%10.24%11.58%14.84%
Gross Profit
1,3491,2861,2271,2081,1881,1111,0941,0921,0941,0431,015992.81,0391,1301,0901,0651,1051,0421,020998.5
Operating Income
513.2477.6151.1307.1411.2394.8312.6350.6366.5349346.8365.9263.5388.4447.8402.4459.5438.8374.4390.3
Net Income
241.9380.791.2291.1333.2358385.63,071366.3351.9369.9384.9307.1340.5398.4343.5406.4373.6335.3340.1
Earnings Per Share
0.420.660.160.500.560.610.655.130.610.580.610.630.500.560.650.550.650.590.530.54
EPS Growth
-25.00%8.20%-75.39%-90.25%-8.20%5.17%6.56%714.29%22.00%3.57%-6.15%14.54%-23.08%-5.08%22.64%1.85%-16.67%9.26%8.16%3.85%

Revenue by Segment
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Transcatheter Aortic Valve Replacement
1,2581,1971,1601,1501,1311,0471,0361,0231,0391,008979.4960.9991.6947.9867.7862.3906.9881.3871.5857.8
Transcatheter Mitral and Tricuspid Therapies
198.6175.1155.7145.2134.5115.2105.191.18372.95652.447.641.631.529.727.92725.322.3
Surgical Structural Heart
284.1276.2253.6258266.8250.9244.4240247.8249.1231230.1256.3248.2224.1219.7228.5220.8221.3217.4
Revenue (Total)
1,7411,6491,5701,5531,5321,4131,3861,3541,3691,3301,2661,2431,2961,4601,3481,3191,3741,3411,3301,310

Cash & Debt
Chart
Fiscal QuarterQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period EndingMar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Cash & Investments
3,6724,2263,8424,0623,8993,9764,4461,9901,6981,6331,8641,5091,2541,2151,7391,5161,4961,4671,7951,561
Total Debt
702.9705.4700.3702.6699.4700706.7693699.2685.1691.1684.5687.8691.3686.8682.8688.2690.3684.1684.2
Net Cash (Debt)
2,9693,5213,1423,3603,1993,2763,7391,297998.4947.71,173824.8566.45241,052833807.7776.51,111877
Net Cash Growth
-7.21%7.48%-15.98%159.07%220.42%245.67%218.84%57.23%76.27%80.86%11.49%-0.98%-29.88%-32.52%-5.29%-5.02%13.94%9.72%83.51%82.97%
Net Cash Per Share
5.116.055.365.715.445.556.252.151.651.561.921.350.930.851.681.331.281.231.761.39

Cash Flow & CapEx
Chart
Fiscal QuarterQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period EndingMar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Operating Cash Flow
43.8450.9573.7290.2280.4-127.5351.8371.5-53.5136.6411.533.6314.1282.8309.9332.2293.3373.6531.9526.1
Capital Expenditures
-64.9-97.4-57.5-49.3-56-49.8-51.9-85.4-65.3-88.3-55.3-47.9-61.5-68.9-59.9-43.1-72.7-89.8-60.7-69.3
Free Cash Flow
-21.1353.5516.2240.9224.4-177.3299.9286.1-118.848.3356.2-14.3252.6213.9250289.1220.6283.8471.2456.8
Free Cash Flow Growth
--72.12%-15.80%---15.81%---77.42%42.48%-14.51%-24.63%-46.94%-36.71%13.42%-0.98%317.73%271.38%

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
77.46%78.01%78.15%77.77%77.52%78.65%78.91%80.59%79.88%78.43%80.18%79.85%80.17%77.43%80.87%80.76%80.39%77.68%76.72%76.21%
Operating Margin
29.48%28.97%9.63%19.77%26.84%27.95%22.56%25.89%26.76%26.24%27.38%29.43%20.34%26.61%33.21%30.51%33.44%32.72%28.16%29.79%
Pretax Margin
29.86%27.84%5.76%22.43%26.12%30.71%28.15%29.74%28.04%27.91%29.00%31.17%21.24%27.31%34.07%30.88%33.82%32.52%28.30%29.84%
Profit Margin
13.87%23.09%4.09%18.82%21.92%25.74%24.90%26.74%26.58%24.43%26.30%26.93%19.62%23.33%29.55%26.04%29.58%27.86%25.22%25.96%
FCF Margin
0.00%-1.28%22.52%33.24%15.72%15.88%-12.79%22.14%20.89%-8.93%3.81%28.65%-1.10%17.31%15.86%18.95%21.04%16.45%21.34%35.96%

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
51.9942.6046.5833.5211.2510.3510.629.5238.0141.1933.1529.6141.7434.3330.5835.6241.1648.2554.4348.17
Forward PE
29.5227.0430.9330.1631.6129.5831.1926.7832.3734.6828.4125.8636.1032.9130.3531.3636.1546.0852.9848.30
P/FCF Ratio
-42.4137.0856.1678.2167.11150.3175.5097.30212.1171.3051.9881.6649.8646.6249.0546.6051.0757.4950.15
PS Ratio
8.007.338.167.688.097.698.017.3210.6811.219.157.8610.589.1110.179.5411.0113.6615.4513.87